Learnings from HIMMS Global Health Conference 2024
Over 35,000 leaders from 30 different countries are attending HIMSS Global Health Conference & Exhibition, which kicked off on March 11th and will continue to inspire until March 15th. Clinakos Inc. is thrilled to be part of this action. Meanwhile, here are a few themes we have seen at the conference and our meetings at […]
ViVE Conference 2024
The ViVE conference concluded last week with significant enthusiasm surrounding the latest advancements in healthcare. At the core of the conference, there was a strong commitment to integrating data, AI, and ethical principles. Industry leaders, practitioners, and innovators converged to explore the intersection of these forces, shaping the future of healthcare. From personalized care to […]
Clinakos Supports Rare Disease Day
Cumulatively, there are more than 10,000 rare diseases affecting over 30 million Americans. 70% of these diseases begin in childhood, and 72% of them have a genetic basis. Additionally, nearly 1 out of 5 cancers is considered rare. Unfortunately, many rare disease patients face significant challenges before receiving a proper diagnosis, and even after diagnosis, […]
Meet us at 20th Annual World Symposium 2024
Feeling incredibly energized at the World Symposium (20th Annual World Symposium 2024) in San Diego. The passion and dedication of everyone involved in Lysosomal Diseases research is truly inspiring.This year’s event dived into a diverse range of Lysosomal disorders including Fabry, Pompe, Gaucher and MLD, understanding the underlying mechanisms of diseases to developing effective treatments.Several amazing […]
Meet us at JP Morgan Chase & Co.’s 42nd Annual JP Morgan Healthcare Conference
Clinakos Inc. will be at JPM2024 meeting clients, collaborators and industry colleagues to kick off a great 2024! We continue to be passionate about leveraging Patient Data and AI to further the progress in life sciences and healthcare. Reach out if you want to connect.
How Digital Twins are Reshaping Healthcare and Pharma
McKinsey & Company research indicates that 70% of C-suite technology executives at large enterprises are already exploring and investing in digital twins. Interest in digital twins, combined with rapidly advancing supportive technologies, is spurring market estimates for digital-twin investments of more than $48 billion by 2026. Patient Digital Twins are now reshaping healthcare and pharma through their […]
Happy Holidays from Clinakos
Warm holiday greetings and a Happy New Year 2024 to everyone! As we bid farewell to an outstanding 2023, Clinakos Inc. celebrates our remarkable growth and continued recognition from clients, partners, and patients. Your unwavering support is deeply appreciated, and we eagerly look forward to expanding our partnership in the upcoming year. Here’s to a prosperous […]
Join us at Piper Sandler’s 35th Annual Healthcare Conference
Join Clinakos Inc. at Piper Sandler ‘s 35th Annual Healthcare Conference in New York. Our team will be on-site from Tuesday, November 28th to Thursday, November 30th, engaging with clients and forging new partnerships.
Happy Thanksgiving from Clinakos
As we usher into the holiday season, Clinakos thanks and salutes our customers, partners, employees and patients for a yet another phenomenal year of growth. We remain committed to our mission of bettering human health through solutions built on the top of Integrated Patient Data and Medically Smart AI. Wishing you all a Thanksgiving filled […]
Over 375 industry leaders from 55+ Pharma & Biotech companies registered for our webinar
Over 375 industry leaders from 55+ Pharma & Biotech companies registered for our webinar “Leveraging Patient Data and AI for Life Science Product Launches”. The list included Abbott, Amgen, AstraZeneca, BioMarin Pharmaceutical Inc., Bristol Myers Squibb, Biogen, Eli Lilly and Company, Genentech, Gilead Sciences, Jazz Pharmaceuticals, Kyowa Kirin, Inc.- U.S., Reata Pharmaceuticals, Inc., The Janssen Pharmaceutical Companies of Johnson & Johnson, Merck, Merck Group, Moderna, Novartis, PTC Therapeutics, Inc., Regeneron, Takeda, Takeda Oncology, Sanofi, UCB, Pfizer and many others. In this webinar, […]
